VenoStent, Inc.

VenoStent, Inc. is a clinical-stage medical device and tissue engineering company based in Houston, Texas. Founded in 2017, the company focuses on developing bioabsorbable polymer scaffolds to enhance outcomes in vascular surgery, particularly for vascular access and bypass grafting. The flagship product, SelfWrap, is a bioabsorbable wrap designed to provide a tailored fit for patients undergoing vascular procedures. This innovative device aims to reduce complications associated with permanent implants by being absorbed by the body. VenoStent's products are currently in the research and development phase and are available only through clinical trials. Supported by investors like Y Combinator, VenoStent has raised nearly $30 million in funding. The company employs a team of 20 to 50 people and utilizes modern technology stacks for its operations. VenoStent is dedicated to improving surgical outcomes for healthcare providers and patients in need of advanced vascular surgery solutions.

• Employees34
• Founded2017
• Annual Revenue$9800000
• Total Funding$26627824